Table 2.
Variables in the equation | P-value | Hazard ratio | 95% confidence interval |
---|---|---|---|
Age | |||
<45 vs ≥45 years | 0 | 0.452 | 0.329–0.621 |
Sex | |||
Female vs male | 0.422 | 1.135 | 0.834–1.544 |
Histology | |||
LGG vs HGG | 0.002 | 1.624 | 1.187–2.223 |
KPS | |||
<70 vs ≥70 | 0.057 | 1.350 | 0.991–1.839 |
Tumor side | 0.474 | ||
Left vs right vs middle vs other | |||
Functional involvement | 0.373 | ||
Eloquent vs near-eloquent vs non-eloquent | |||
RDW | |||
<13.95 vs ≥13.95 | 0.074 | 1.328 | 0.973–1.813 |
NLR | |||
<4 vs ≥4 | 0.037 | 1.385 | 1.020–1.881 |
Platelet count (×109/L) | |||
<400 vs ≥400 | 0.167 | 1.522 | 0.839–2.759 |
Abbreviations: LGG, low-grade gliomas; HGG, high-grade gliomas; KPS, Karnofsky performance score; RDW, red cell distribution width; NLR, neutrophil–lymphocyte ratio.